Does a loss of TDP-43 function cause neurodegeneration?

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Xu, Zuo Shang ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; TAR DNA BINDING PROTEIN;

ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; CYTOPLASM; FRONTOTEMPORAL DEMENTIA; GAIN OF FUNCTION MUTATION; GENE; GENE OVEREXPRESSION; HUMAN; HYPOTHESIS; LOSS OF FUNCTION MUTATION; MAMMAL CELL; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STOICHIOMETRY;

ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DNA-BINDING PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION;

EID: 84862210719     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-27     Document Type: Review

References (95)

1. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Science 2006 314 130 133 (Pubitemid 44547757)
2. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T, Biochem Biophys Res Commun 2006 351 602 611 (Pubitemid 44708852)
3. Amyotrophic lateral sclerosis. Rowland LP, Shneider NA, N Engl J Med 2001 344 1688 1700 (Pubitemid 32479968)
4. Adult motor neuron disease. Munsat TL, Merritt's textbook of neurology Lea & Febiger, Philadelphia, Rowland LP, 1989 682 687
5. Frontotemporal dementia: a review for primary care physicians. Cardarelli R, Kertesz A, Knebl JA, Am Fam Physician 2010 82 1372 1377
6. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Geser F, Lee VM, Trojanowski JQ, Neuropathology 2010 30 103 112
7. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia. Fecto F, Siddique T, J Mol Neurosci 2011 45 663 675
8. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Lagier-Tourenne C, Polymenidou M, Cleveland DW, Hum Mol Genet 2010 19 46 64
9. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, et al. Nature 2011 477 211 215
10. A Hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Renton Alan E, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick Jennifer C, Laaksovirta H, Van Swieten John C, Myllykangas L, et al. Neuron 2011 72 257 268
11. Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. DeJesus-Hernandez M, DeJesus-Hernandez M, Mackenzie Ian R, Boeve Bradley F, Boxer Adam L, Baker M, Rutherford Nicola J, Nicholson Alexandra M, Finch NiCole A, Flynn H, Adamson J, et al. Neuron 2011 72 245 256
12. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Da Cruz S, Cleveland DW, Curr Opin Neurobiol 2011 21 904 919
13. Structural determinants of the cellular localization and shuttling of TDP-43. Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE, J Cell Sci 2008 121 3778 3785
14. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. Buratti E, Baralle FE, RNA Biol 2010 7 420 429
15. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. Nat Neurosci 2011 14 459 468
16. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V, et al. Nat Neurosci 2011 14 452 458
17. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Kawahara Y, Mieda-Sato A, Proc Natl Acad Sci 2012 109 3347 3352
18. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. Freibaum BD, Chitta RK, High AA, Taylor JP, J Proteome Res 2010 9 1104 1120
19. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW, Proc Natl Acad Sci USA 2010 107 13318 13323
20. Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes. Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, et al. J Biol Chem 2010 286 1204 1215
21. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. Kim SH, Shanware NP, Bowler MJ, Tibbetts RS, J Biol Chem 2010 285 34097 34105
22. TDP-43 regulates its mRNA levels through a negative feedback loop. Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, Baralle FE, EMBO J 2011 30 277 288
23. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, et al. J Neurosci 2010 30 10851 10859
24. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, Malunda J, Xu Y, Winton MJ, Trojanowski JQ, Lee VM, J Clin Invest 2011 121 726 738
25. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Wu L-S, Cheng W-C, Hou S-C, Yan Y-T, Jiang S-T, Shen CKJ, Genesis 2010 48 56 62
26. TDP-43 is a developmentally-regulated protein essential for early embryonic development. Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P, Herz J, Yu G, J Biol Chem 2009 285 6826 6834
27. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, Lee VM, Schellenberg GD, Acta Neuropathol 2010 119 409 419
28. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al. Science 2008 319 1668 1672 (Pubitemid 351432505)
29. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde CV, Bouchard J-P, Lacomblez L, Pochigaeva K, Salachas F, et al. Nat Genet 2008 40 572 574 (Pubitemid 351601218)
30. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. Feiguin F, Godena VK, Romano G, D'Ambrogio A, Klima R, Baralle FE, FEBS Lett 2009 583 1586 1592
31. Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. Lu Y, Ferris J, Gao FB, Mol Brain 2009 2 30
32. A Drosophila model for TDP-43 proteinopathy. Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, Woodruff EA, Fushimi K, Wu JY, Proc Natl Acad Sci USA 2009 107 3169 3174
33. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC, Hum Mol Genet 2011 20 2308 2321
34. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD, J Clin Invest 2011 121 4118 4126
35. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, Rochefort D, Bel Hadj S, Durham HD, Vande Velde C, et al. Hum Mol Genet 2010 19 671 683
36. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Chiang P-M, Ling J, Jeong YH, Price DL, Aja SM, Wong PC, Proc Natl Acad Sci 2010 107 16320 16324
37. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH, Proc Natl Acad Sci 2009 106 18809 18814
38. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Xu YF, Zhang YJ, Lin WL, Cao X, Stetler C, Dickson DW, Lewis J, Petrucelli L, Mol Neurodegener 2011 6 73
39. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. Zhou H, Huang C, Chen H, Wang D, Landel CP, Xia PY, Bowser R, Liu YJ, Xia XG, PLoS Genet 2010 6 1000887
40. Progressive motor weakness in transgenic mice expressing human TDP-43. Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL, Neurobiol Dis 2010 40 404 414
41. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S, Proc Natl Acad Sci 2010 107 3858 3863
42. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, Julien JP, Brain 2011 134 2610 2626
43. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Shan X, Chiang P-M, Price DL, Wong PC, Proc Natl Acad Sci 2010 107 16325 16330
44. Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span. Zhang T, Hwang HY, Hao H, Talbot C, Wang J, J Biol Chem 2012 287 8371 8382
45. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Mackenzie IRA, Rademakers R, Neumann M, Lancet Neurol 2010 9 995 1007
46. The Microprocessor complex mediates the genesis of microRNAs. Gregory RI, Yan K-p, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R, Nature 2004 432 235 240 (Pubitemid 39545855)
47. Kinesin-2 is a motor for late endosomes and lysosomes. Brown CL, Maier KC, Stauber T, Ginkel LM, Wordeman L, Vernos I, Schroer TA, Traffic 2005 6 1114 1124 (Pubitemid 41632264)
48. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD, J Biol Chem 2009 284 20329 20339
49. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, et al. Proc Natl Acad Sci USA 2009 106 7607 7612
50. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. Yang C, Tan W, Whittle C, Qiu L, Cao L, Akbarian S, Xu Z, PLoS One 2010 5 15878
51. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, et al. Nat Struct Mol Biol 2011 18 822 830
52. TDP-43 depletion induces neuronal cell damage through dysregulation of rho family GTPases. Iguchi Y, Katsuno M, Niwa J-i, Yamada S-i, Sone J, Waza M, Adachi H, Tanaka F, Nagata K-i, Arimura N, et al. J Biol Chem 2009 284 22059 22066
53. Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. van Eersel J, Ke YD, Gladbach A, Bi M, Gotz J, Kril JJ, Ittner LM, PLoS One 2011 6 22850
54. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. D'Ambrogio A, Buratti E, Stuani C, Guarnaccia C, Romano M, Ayala YM, Baralle FE, Nucleic Acids Res 2009 37 4116 4126
55. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M, Hum Mol Genet 2009 18 3353 3364
56. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Lee EB, Lee VMY, Trojanowski JQ, Nat Rev Neurosci 2011 13 38 50
57. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, et al. PLoS Genet 2008 4 1000193
58. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 Proteinopathies. Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VMY, J Biol Chem 2009 284 8516 8524
59. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS, Nucleic Acids Res 2009 37 1799 1808
60. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S, J Neurosci 2010 30 639 649
61. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. Liachko NF, Guthrie CR, Kraemer BC, J Neurosci 2010 30 16208 16219
62. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Johnson BS, McCaffery JM, Lindquist S, Gitler AD, Proc Natl Acad Sci 2008 105 6439 6444 (Pubitemid 351758364)
63. Neurotoxic effects of TDP-43 overexpression in C. elegans. Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, Buratti E, Petrucelli L, Link CD, Hum Mol Genet 2010 19 3206 3218
64. TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. Zhang T, Mullane PC, Periz G, Wang J, Hum Mol Genet 2011 20 1952 1965
65. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS, J Neuropathol Exp Neurol 2007 66 152 157 (Pubitemid 46208736)
66. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation. Ito H, Nakamura M, Komure O, Ayaki T, Wate R, Maruyama H, Nakamura Y, Fujita K, Kaneko S, Okamoto Y, et al. Acta Neuropathol 2011 122 223 229
67. Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations. Deng H-X, Bigio EH, Zhai H, Fecto F, Ajroud K, Shi Y, Yan J, Mishra M, Ajroud-Driss S, Heller S, et al. Arch Neurol 2011 68 1057 1061
68. DCTN1 mutations in Perry syndrome. Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, et al. Nat Genet 2009 41 163 165
69. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. Nature 2010 466 1069 1075
70. Adapting proteostasis for disease intervention. Balch WE, Morimoto RI, Dillin A, Kelly JW, Science 2008 319 916 919 (Pubitemid 351263754)
71. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC, J Cell Biol 2009 187 875 888
72. Potentiation of ALS-associated TDP-43 aggregation by the proteasome-targeting factor, Ubiquilin 1. Kim SH, Shi Y, Hanson KA, Williams LM, Sakasai R, Bowler MJ, Tibbetts RS, J Biol Chem 2008 284 8083 8092 M808064200
73. Enrichment of C-terminal fragments in TAR DNA-Binding Protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M, et al. Am J Pathol 2008 173 182 194 (Pubitemid 351947966)
74. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Seilhean D, Cazeneuve C, Thuries V, Russaouen O, Millecamps S, Salachas F, Meininger V, Leguern E, Duyckaerts C, Acta Neuropathol 2009 118 561 573
75. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S, Neuropathology 2010 30 408 419
76. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, Perl DP, Hedley-Whyte ET, Price B, Sullivan C, et al. J Neuropathol Exp Neurol 2010 69 918 929
77. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M, J Neuropathol Exp Neurol 2008 67 555 564 (Pubitemid 351787082)
78. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, et al. Acta Neuropathol 2007 114 221 229 (Pubitemid 47226148)
79. Does alpha-amino-beta-methylaminopropionic acid (BMAA) play a role in neurodegeneration? Chiu AS, Gehringer MM, Welch JH, Neilan BA, Int J Environ Res Public Health 2011 8 3728 3746
80. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Callaghan B, Feldman D, Gruis K, Feldman E, Neurodegener Dis 2011 8 1 8
81. Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates. Costanza A, Weber K, Gandy S, Bouras C, Hof PR, Giannakopoulos P, Canuto A, Neuropathol Appl Neurobiol 2011 37 570 584
82. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Migliore L, Coppede F, Mutat Res 2009 667 82 97
83. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C, Mol Cell Neurosci 2007 35 320 327 (Pubitemid 46843567)
84. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Brandmeir NJ, Geser F, Kwong LK, Zimmerman E, Qian J, Lee VM, Trojanowski JQ, Acta Neuropathol 2008 115 123 131 (Pubitemid 50003187)
85. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, Wakabayashi K, Acta Neuropathol 2008 116 193 203
86. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, Pellerino A, Buccinna B, Lupino E, Rinaudo MT, Brain Pathol 2010 20 351 360
87. Acute and chronically increased immunoreactivity to phosphorylation- independent but not pathological TDP-43 after a single traumatic brain injury in humans. Johnson VE, Stewart W, Trojanowski JQ, Smith DH, Acta Neuropathol 2011 122 715 726
88. Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL/ mice: support for a role for TDP-43 in the physiological response to neuronal injury. Moisse K, Mepham J, Volkening K, Welch I, Hill T, Strong MJ, Brain Res 2009 1296 176 186
89. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury. Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, Strong MJ, Brain Res 2009 1249 202 211
90. Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons. Sato T, Takeuchi S, Saito A, Ding W, Bamba H, Matsuura H, Hisa Y, Tooyama I, Urushitani M, Neuroscience 2009 164 1565 1578
91. VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death. Gitcho MA, Strider J, Carter D, Taylor-Reinwald L, Forman MS, Goate AM, Cairns NJ, J Biol Chem 2009 284 12384 12398
92. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, Tang W, Winton MJ, Neumann M, Trojanowski JQ, et al. J Neurosci 2010 30 7729 7739
93. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderweyde T, Citro A, Mehta T, Zaarur N, McKee A, Bowser R, Sherman M, et al. PLoS One 2010 5 13250
94. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Parker SJ, Meyerowitz J, James JL, Liddell JR, Crouch PJ, Kanninen KM, White AR, Neurochem Int 2012 60 415 424
95. TDP-43 aggregation in neurodegeneration: are stress granules the key? Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G, Brain Res 2012 Epub ahead of print at http://www.sciencedirect.com/science/article/pii/ S0006899312003095.